D61.1 Billable / specific Drug-induced aplastic anemia
ICD-10-CM D61.1 identifies “Drug-induced aplastic anemia” as a billable/specific code in the FY2027 U.S. classification, effective October 1, 2026 through September 30, 2027.
Chapter 3: Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism
Code-level instructions
Use additional code1
code for adverse effect, if applicable, to identify drug (T36-T50 with fifth or sixth character 5)
Inherited instructions
Chapters 3 · Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism (D50-D89)
Excludes 29
- autoimmune disease (systemic) NOS (M35.9)
- certain conditions originating in the perinatal period (P00-P96)
- complications of pregnancy, childbirth and the puerperium (O00-O9A)
- congenital malformations, deformations and chromosomal abnormalities (Q00-Q99)
- endocrine, nutritional and metabolic diseases (E00-E88)
- human immunodeficiency virus [HIV] disease (B20)
- injury, poisoning and certain other consequences of external causes (S00-T88)
- neoplasms (C00-D49)
- symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified (R00-R94)
D61 · Other aplastic anemias and other bone marrow failure syndromes
Excludes 21
neutropenia (D70.-)
Official index references
Official index references (2)
Anemia(essential) (general) (hemoglobin deficiency) (infantile) (primary) (profound) (2)
References from other codes (5)
Excludes 2 · drug-induced aplastic anemia (D61.1)
Excludes 2 · aplastic anemia due to antineoplastic chemotherapy (D61.1)
Excludes 2 · aplastic anemia due to drugs (D61.1)
Excludes 1 · aplastic anemia due to antineoplastic chemotherapy (D61.1)
Excludes 2 · aplastic anemia due to antineoplastic chemotherapy (D61.1)
History
Code history
Latest recorded change · FY2021
Effective from
- Inherited rules changed
Drug-induced aplastic anemia
Billable diagnosis code
CDC/NCHS · FY2021All editions (19)
| All editions | Effective from | Code history |
|---|---|---|
| FY2016 | 2015-10-01 | First observed |
| FY2017 | 2016-10-01 | No tabular change |
| FY2018 | 2017-10-01 | No tabular change |
| FY2019 | 2018-10-01 | No tabular change |
| FY2020 | 2019-10-01 | No tabular change |
| FY2020 · April | 2020-04-01 | No tabular change |
| FY2021 | 2020-10-01 | Inherited rules changed |
| FY2021 · 01-01 | 2021-01-01 | No tabular change |
| FY2022 | 2021-10-01 | No tabular change |
| FY2022 · 04-01 | 2022-04-01 | No tabular change |
| FY2023 | 2022-10-01 | No tabular change |
| FY2023 · 04-01 | 2023-04-01 | No tabular change |
| FY2024 | 2023-10-01 | No tabular change |
| FY2024 · 04-01 | 2024-04-01 | No tabular change |
| FY2025 | 2024-10-01 | No tabular change |
| FY2025 · 04-01 | 2025-04-01 | No tabular change |
| FY2026 | 2025-10-01 | No tabular change |
| FY2026 · April | 2026-04-01 | No tabular change |
| FY2027 | 2026-10-01 | No tabular change |
Historical ICD-9 mappings · 2018
Historical mapping only; not an automatic code substitution.
- 284.89 · Approximate
This entry is a complete code in the selected edition. Reference checks do not establish clinical appropriateness or guarantee reimbursement.